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THE GROWTH OF HEALTH LAW AND
BIOETHICS
Mark A. Rothsteint
LOOKING BACK over the last fifty years, the growth in health
law and bioethics has been nothing short of amazing. Although health
law barely existed as a discipline fifty years ago, today health issues
have created entire new fields of law, ranging from food and drug law
to fraud and abuse law. Similarly, in the last fifty years, law has be-
come an integral (if not universally welcomed) part of medicine. Phy-
sician practices are now concerned with privacy notices, informed
consent documents, and advanced directives. At most hospitals, ex-
panded in-house legal departments have been joined by related de-
partments of risk management, regulatory compliance, and health
information privacy and security.
Overarching both law and medicine is bioethics, a still-emerging
discipline that blends philosophy, law, and social science. A major
intellectual source of modem bioethics was the enactment of the Nur-
emburg Code after World War II, although the actual term "bioethics"
was not used until the latel960s.1 Today, bioethics includes research
ethics, 2 clinical ethics, 3 distributional ethics, 4 as well as other con-
cers. Bioethics plays an important role at both the individual and
societal levels. It is the link between private morality, professional
t J.D.; Herbert F. Boehl Chair of Law and Medicine, Director, Institute for
Bioethics, Health Policy and Law, University of Louisville School of Medicine.
1 ALBERT R. JONSEN, THE BIRTH OF BIOETHICS vii (1998). See also VAN
RENSSELAER POTTER, BIOETHICS: BRIDGE TO THE FUTURE 2 (Carl P. Swanson ed.,
1971) ("1 ... propose the term Bioethics in order to emphasize [the important roles of
both] biological knowledge and human values.").
2 E.g., BARUCH A. BRODY, THE ETHICS OF BIOMEDICAL RESEARCH: AN
INTERNATIONAL PERSPECTIVE (1998). See also REBECCA DRESSER, WHEN SCIENCE
OFFERS SALVATION: PATIENT ADVOCACY AND RESEARCH ETHICS (2001); COMM. ON
ASSESSING THE SYSTEM FOR PROTECTING HUM. RES. PARTICIPANTS, INST. OF MED.,
RESPONSIBLE RESEARCH: A SYSTEMS APPROACH TO PROTECTING RESEARCH
PARTICIPANTS (Daniel D. Federman et al. eds., 2003).
3 E.g., ALBERT R. JONSEN ET AL., CLINICAL ETHICS: A PRACTICAL APPROACH
TO ETHICAL DECISIONS IN CLINICAL MEDICINE (John Dolan & P. McCurdy eds., 4th
ed. 1998).
4 E.g., NORMAN DANIELS, JUST HEALTH CARE (Daniel I. Wikler et al. eds.,
1985); MEDICINE AND SOCIAL JUSTICE: ESSAYS ON THE DISTRIBUTION OF HEALTH
CARE (Rosamond Rhodes et al. eds., 2002).
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responsibility, and public policy. Nevertheless, there are no accred-
ited or agreed-upon training programs in the field; there is frequent
suspicion of the competence and motives of the self-appointed "secu-
lar priests" who serve as bioethicists; and there is no consensus on the
weight to be given to bioethical analyses in individual cases or in pol-
icy development.
Against this backdrop of explosive growth and poorly defined
boundaries in health law and bioethics,5 it is valuable to attempt to put
these developments into perspective. Those who work in health law
and bioethics need to recognize the origins of the fields as well as the
substantial challenges ahead. I will concentrate my discussion on five
areas.
First, health care is now big business. In the United States, health
care spending in 2001 was $1.4 trillion, representing approximately
14.1 percent of GDP. 6 The practice of medicine is increasingly con-
centrated in large conglomerates, including for-profit health care de-
livery companies and managed care organizations.7 The biotech,
pharmaceutical, and medical device industries are all billion dollar
industries, and their importance to medical care continues to grow.
Finally, the health insurance industry, by pre-approving or rejecting
medical interventions, has in many instances blurred the distinctions
between those who provide health care and those who provide reim-
bursement for health care. Obviously, the practice of medicine today
no longer resembles the time when physicians made house calls and
received payment in cash.8
Second, much of the growth in health care has been driven by new
technology. We sometimes take for granted the range of medical
miracles of so recent vintage, including advances in areas such as di-
agnostic imaging, laparoscopic- and micro-surgery, renal dialysis,
organ transplantation, artificial joints, assisted reproductive technolo-
gies, and genetic analysis. With each new advance in medicine come
such inevitable questions as when is a new device, medication, or
5 E.g., Mark A. Hall. Law, Medicine and Trust, 55 STAN. L. REV. 463, 464-
65 (2002) ("[U]nlike other areas of law, no unifying principle or animating concern
has yet been identified for the law of health care delivery.").
6 CENTERS FOR MEDICARE AND MEDICAID SERVICES, REPORT DETAILS
NATIONAL HEALTH CARE SPENDING INCREASES IN 2001, at
http://cms.hhs.gov/media/press/release.asp?Counter-693 (Jan. 8, 2003).
7 E.g., MARY R. ANDERLIK, THE ETHICS OF MANAGED CARE: A PRAGMATIC
APPROACH 179 (2001) ("Corporations have long been a part of health care. What is
unprecedented is the consolidation among corporations and the extension of the cor-
porate domain to include physicians.").
8 PAUL STARR, THE SOCIAL TRANSFORMATION OF AMERICAN MEDICINE 66-
71(1982).
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procedure ready to move from research to the clinic; who should have
access to it; who will pay for it; and how will it be regulated.9 The
ability to attempt more complex medical procedures, along with the
diffuse responsibility for care, means an increased risk of adverse
outcomes. Efforts to reduce medical errors and to compensate victims
of error continue to be sources of great controversy.' 0
Third, numerous specialty areas of health law practice and study
have been created by the enactment of federal and state regulatory
statutes. Medicare, Medicaid, and other government-sponsored health
finance programs, originally opposed in the mid-1960s by organized
medicine," dominate today's health care reimbursement system, and
require a detailed knowledge of specific laws and regulations. Subse-
quent legislation included the Employee Retirement Income Security
Act (ERISA),' 2 Emergency Medical Treatment and Active Labor Act
(EMTALA), 13 Americans with Disabilities Act (ADA), 14 Health In-
surance Portability and Accountability Act (HIPAA), 15 and other laws
regulating such issues as health finance, health services, disability
discrimination, and privacy. While rejecting comprehensive reforms,
the U.S. health care "system" has mutated incrementally into an
amorphous mass of laws and regulations, each enacted with good in-
tentions but, cumulatively, achieving unsatisfactory results by nearly
any measure of population health. Increasingly, policy makers will
need to focus on substantially improving measures of population
health, such as infant mortality rates, childhood immunization rates,
and life expectancy.
Fourth, patients have changed over the last fifty years, and so
have their relationships with health care providers. The physician-
patient relationship fifty years ago was characterized by paternalism,
in which largely white, male, generalist physicians provided care on
their own terms. It was common for doctors to withhold diagnostic
9 See ETHICAL DIMENSIONS OF HEALTH POLICY (Marion Danis et al. eds.,
2002) (exploring questions of regulatory authority, resource distribution, and their
influence on each other).
10 See generally COMvM. ON QUALITY OF HEALTH CARE IN AMERICA, INST. OF
MED., To ERR is HUMAN: BUILDING A SAFER HEALTH SYSTEM (Linda T. Kohn et al.
eds., 2001). See also E. HAAVI MORREIM, HOLDING HEALTH CARE ACCOUNTABLE:
LAW AND THE NEW MEDICAL MARKETPLACE (2001); MARGIN OF ERROR: THE ETHICS
OF MISTAKES IN THE PRACTICE OF MEDICINE (Susan B. Rubin & Laurie Zoloth, eds.,
2000).
1 STARR, supra note 8, at 367-78.
12 29 U.S.C. §§ 1003-1191 (2000).
'3 42 U.S.C. § 1395dd (2000).
14 42 U.S.C. §§ 12101-12213 (2000).
1" Pub. L. No. 104-191, 110 Stat. 1936 (1996) (codified as amended in scat-
tered sections of 42 U.S.C.).
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and prognostic information from their patients on the grounds that
they wouldn't understand the information or were better off not know-
ing.' 6 Physicians are more diverse today in terms of ethnicity and
gender, and patients are usually more informed about and interested in
their own health. Diagnosis and treatment are based on principles of
informed consent, patient autonomy, and shared decision making after
disclosure of all relevant information.' 7 Growth in telemedicine and
e-health, the expanding scope of practice by allied professionals, and
complementary and alternative medicine will further complicate phy-
sician-patient relations.
Fifth, the Human Genome Project, which formally began in 1990,
has committed three to five percent of its annual scientific research
budget to the study of the ethical, legal, and social implications of
genome research.' 8 This Ethical, Legal, and Social Implications
(ELSI) program has channeled millions of dollars into bioethics and
health law research. Both the amount of money and the timing of the
ELSI research (concurrent with the scientific research) are unprece-
dented.' 9 The ELSI program has been subject to various criticisms,
including that it is an attempt to buy off potential critics.20 Neverthe-
less, ELSI grantees have generated a substantial number of excellent
studies and publications, many with applications well beyond genom-
ics, which have served to promote an awareness of key issues. 2' It
remains to be seen whether other biomedical research undertakings
16 See, e.g., DAVID J. ROTHMAN, STRANGERS AT THE BEDSIDE: A HISTORY OF
HOW LAW AND BIOETHICS TRANSFORMED MEDICAL DECISION MAKING 1-2 (1991)
("Well into the post-World War 11 period, decisions at the bedside were the almost
exclusive concern of the individual physician, even when they raised fundamental
ethical and social issues.").
17 E.g., A HISTORY AND THEORY OF INFORMED CONSENT 274-82 (Ruth R.
Faden et al eds., 1986) (explaining the role of the patient or research subject in au-
thorizing treatment or experimentation rather than merely assenting or acquiescing).
But see CARL E. SCHNEIDER, THE PRACTICE OF AUTONOMY: PATIENTS, DOCTORS, AND
MEDICAL DECISIONS (1998) (discussing research that shows that many patients do not
want autonomy, the reasons why, and what decisions they should be required to
make).
18 ROBERT M. COOK-DEEGAN, THE GENE WARS: SCIENCE, POLITICS AND THE
HUMAN GENOME 255 (1994).
" See id. at 245-55 (1994) (describing the ELSI program as "an attempt to
articulate the values that should govern the research, and to anticipate adverse social
consequences of science in time to avert them." Id. at 248.).
20 Eric T. Juengst, Self-Critical Federal Science? The Ethics Experiment
Within the U.S. Human Genome Project, 13 SOC. PHIL. & POL'Y 63, 67 (1996)
(evaluating various criticisms of the ELS1 program).
21 For a list of ELSI publications, refer to their website,
http://www.genome.gov/10001798.
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will similarly commit to studying the ethical, legal, and social impli-
cations of their research.
One thing is clear from this brief review: health law and bioethics
are here to stay. In a culture dominated by law, health law establishes
the standards for individual, professional, and institutional conduct
and relations. In a pluralistic and diverse society, bioethics serves to
frame the secular moral discourse on issues ranging from cloning to
physician-assisted suicide. Yet, health law and bioethics must move
beyond a boutique area of law practice and an abstract academic pur-
suit. Professional education and health policy development present
important challenges for health law and bioethics.
A major limitation on incorporating health law and bioethics into
the legal and health professions is that legal and medical educators
have yet to determine whether or how to integrate health law and bio-
ethics into professional and continuing education. Although the pro-
liferation of health law courses at some law schools suggests a grow-
ing recognition of the importance of the subject; at even those law
schools with an emphasis on health law, curricular coherence and
integration are often lacking. At most law schools, health law is
barely a part of the curriculum. Furthermore, very few law schools
offer any instruction in public health law, now an important part of
national security planning and infection control at all levels of gov-
ernment.
The ethics education situation is even worse at schools of medi-
cine, dentistry, nursing, and public health. For example, medical eth-
ics instruction typically has involved a series of lectures by non-
clinician faculty members. Because the material is usually neither on
medical school examinations nor national boards and the subject is not
taught by "real doctors," medical ethics instruction usually has been
received with little enthusiasm by medical students. There is an ur-
gent need to modernize medical ethics instruction, to integrate it over
the four years of medical school, to relate it more closely to the study
and practice of medicine, and to include essential legal principles. In
mid-2004, the United States Medical Licensing Examination (Step 2)
will begin including a clinical skills examination.22 If, in the future, a
clinical ethics component were added to the national clinical skills
examination it would quickly lead to a greater emphasis on ethics
instruction in medical schools and an integration of ethics into clinical
instruction.
22 United States Medical Licensing Examination, Step 2 Clinical Skills Ex-
anination: Frequently Asked Questions, at
http://www.usmle.org/news/cse/step2csfaqs1 103.htm (last updated Nov. 5, 2003).
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Health law and bioethics also need to play a more important role
in the political process. The occasional national commissions and
task forces charged with bioethics analysis have been too haphazard,
politicized, and ad hoc to develop any continuity or stature in influ-
encing the political process. Bioethics must both inform and be in-
formed by public attitudes; it must apply rigid analytical tools and
methods; 23 and it must promote our unique national mores while rec-
ognizing the increasing importance of international perspectives.
Those of us who work in the field of health law and bioethics need to
become more involved in the political process. We need to move
beyond sound bites and clever quotes in the media to help delineate
the values, interests, and legal foundations on which the health policy
of the future will be based.
23 See generally METHODS IN MEDICAL ETHICS (Jeremy Sugarman & Daniel
P. Sulmasy eds., 2001) (explaining that empirical evidence is necessary to avoid
premature value judgments and moral inferences).
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